Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Bring Naloxone To Opioid Overdoses: FDA Crowd-Sources Smartphone Apps

Executive Summary

FDA announces $40,000 Naloxone App Competition at the start of Prescription Opioid and Heroin Epidemic Awareness Week through Sept. 23, when registration open for the competition, which closes Oct. 7.

Advertisement

Related Content

FDA's OTC Naloxone Study Is A Starting Point For Other Switches, Not A Roadmap
FDA’s Naloxone Product Approval Standards May See Changes
Naloxone Costs Could Temper Non-Rx Access Even As Distribution Spreads
Opioid Abuse: White House Expanding Access To Buprenorphine, Naloxone
Naloxone Switch: Door Opener For Other NDAs That Swing On Consumer Education

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS119161

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel